Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock

Advances in Experimental Medicine and Biology

Volumn 710, Issue , 2012, Pages 107-133

  Li, Yongqing ^a   Alam, Hasan B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APICIDIN; BUTYRIC ACID; CYTOPLASM PROTEIN; ENTINOSTAT; HISTONE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 8; HISTONE DEACETYLASE INHIBITOR; LYSINE; MSK 275; NICOTINAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; ROMIDEPSIN; SURAMIN; TRICHOSTATIN A; TUBACIN; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT;

ACETYLATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOPSY; CELL CULTURE; CELL DEATH; CELL FUNCTION; CELL PROLIFERATION; CELL PROTECTION; CELL REGENERATION; CELL SURVIVAL; CHROMATIN CONDENSATION; DISEASE SEVERITY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; FLUID RESUSCITATION; GENE EXPRESSION REGULATION; GENE SILENCING; HEMORRHAGIC SHOCK; HISTONE MODIFICATION; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; ISCHEMIC PRECONDITIONING; LETHALITY; LEUKOCYTE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; REPERFUSION INJURY; SEPTIC SHOCK; SURVIVAL FACTOR; SURVIVAL RATE; TISSUE PERFUSION; TISSUE REGENERATION; TREATMENT RESPONSE;

ACETYLATION; ANIMALS; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HISTONE DEACETYLASE INHIBITORS; MITOGEN-ACTIVATED PROTEIN KINASES; PARACRINE COMMUNICATION; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REPERFUSION INJURY; SHOCK, HEMORRHAGIC; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; SURVIVAL RATE; TOLL-LIKE RECEPTOR 4;

RODENTIA; SUIDAE;

EID: 84555177969     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-5638-5_11     Document Type: Article

References (154)

1. Adam E, Quivy V, Bex F et al (2003) Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha. Mol Cell Biol 23(17):6200-6209 (Pubitemid 37013097)
2. Alam HB, Shuja F, Butt MU, Duggan M, Li Y, Zacharias N, Fukudome EY, Liu B, Demoya M, Velmahos GC (2009) Surviving blood loss without transfusion in a swine poly-trauma model. Surgery 146(2):325-333
3. Ashburner BP, Westerheide SD, Baldwin AS Jr (2001) The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21(20):7065-7077 (Pubitemid 32916079)
4. Avery J, Etzion S, DeBosch BJ et al (2010) TRB3 function in cardiac endoplasmic reticulum stress. Circ Res 106(9):1516-1523
5. Avila AM, Burnett BG, Taye AA et al (2007) Trichostatin A increases SMN expression and survival in amousemodel of spinal muscular atrophy. J Clin Invest 117:659-671 (Pubitemid 46348524)
6. Ayala A, Chung CS, Lomas J et al (2002) Shock-induced neutrophil mediated priming for acute lung injury in mice: Divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol 161(6):2283-2294 (Pubitemid 35434872)
7. Baker JW, Deitch EA, Li M et al (1988) Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 28(7):896-906
8. Bauhofer A, Lorenz W, Kohlert F et al (2006) Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis. Crit Care Med 34(3):778-784
9. Beere HM, Wolf BB, Cain K et al (2000) Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2(8):469-475
10. Bhatia M, He M, Zhang H et al (2009) Sepsis as a model of SIRS. Front Biosci 14:4703-4711
11. Bianchi ME (2007) DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 81(1):1-5 (Pubitemid 46028489)
12. Blanchard F, Chipoy C (2005) Histone deacetylase inhibitors: New drugs for the treatment of inflammatory diseases? Drug Discov Today 10(3):197-204 (Pubitemid 40222231)
13. Botha AJ, Moore FA, Moore EE et al (1995) Early neutrophil sequestration after injury: A pathogenic mechanism for multiple organ failure. J Trauma 39(3):411-417
14. Buczek-Thomas JA, Hsia E, Rich CB et al (2008) Inhibition of histone acetyltransferase by glycosaminoglycans. J Cell Biochem 105(1):108-120
15. Butler LM, Zhou X, Xu WS et al (2002) The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci USA 99(18):11700-11705 (Pubitemid 34994462)
16. Camelo S, Iglesiuas AH, Hwang D et al (2005) Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol 164:10-21 (Pubitemid 40826758)
17. Cao W, Bao C, Padalko E, Lowenstein CJ (2008) Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J Exp Med 205(6):1491-1503 (Pubitemid 351831502)
18. Carey N, La Thangue NB (2006) Histone deacetylase inhibitors: Gathering pace. Curr Opin Pharmacol 6:369-375 (Pubitemid 44040838)
19. Cha JH (2000) Transcriptional dysregulation in Huntington's disease. Trends Genet 23(9):387-392
20. Champion HR, Bellamy RF, Roberts CP, Leppaniemi A (2003) A profile of combat injury. J Trauma 5:S13-S19 (Pubitemid 36758844)
21. Chang KT, Min KT (2002) Regulation of lifespan by histone deacetylase. Ageing Res Rev 1(3):313-326 (Pubitemid 38340326)
22. Chang JG, Hsieh-Li HM, Jong YJ et al (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 98:9808-9813
23. Chaudry IH, Ayala A (1993) Mechanism of increased susceptibility to infection following hemorrhage. Am J Surg 165(2A Suppl):59S-67S
24. Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5(5):392-401
25. Chen LF, Wu Y, Greene WC (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kB. EMBO J 21(23):6539-6548 (Pubitemid 35448431)
26. Cheng Q, McKeown SJ, Santos L et al (2010) Macrophage migration inhibitory factor increases leukocyteendothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J Immunol 185:1238-1247
27. Chesley A, Lundberg MS, Asai T, Xiao RP, Ohtani S, Lakatta EG, Crow MT (2000) The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res 87:1172-1179
28. Chi H, Flavell RA (2008) Acetylation of MKP = 1 and the control of inflammation. Sci Signal 1(41):pe44
29. Choudhry MA, Bland KI, Chaudry IH (2007) Trauma and immune response-effect of gender differences. Injury 38(12):1382-1391 (Pubitemid 350192397)
30. Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32(11):591-601
31. Dangond F, Gullans SR (1998) Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate. Biochem Biophys Res Commun 247:833-837 (Pubitemid 28418477)
32. de Ruijter AJ, van Gennip AH, Caron HN et al (2003) Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem J 370(Pt 3):737-749 (Pubitemid 36399066)
33. DeBosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ (2006) Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 281:32841-32851 (Pubitemid 46036839)
34. Deitch EA (1992) Multiple organ failure. Pathophysilogy and potential future therapy. Ann Surg 216:117-134
35. Deitch EA (2001) Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care 7(2):92-98 (Pubitemid 32411397)
36. Deitch EA, Bridges W, Ma L et al (1990) Hemorrhagic shock- induced bacterial translocation: The role of neutrophils and hydroxyl radicals. J Trauma 30:942-952 (Pubitemid 20271997)
37. Deitch EA, Xu D, Kaise VL (2006) Role of the gut in the development of injury- and shock induced SIRS and MODS: The gut-lymph hypothesis, a review. Front Biosci 11:520-528 (Pubitemid 43258161)
38. Deng WG, Wu KK (2003) Regulation of inducible nitric oxide synthase expression by p300 and p50 acetylation. J Immunol 171(12):6581-6588 (Pubitemid 37532089)
39. Dokmanovic M, Clarke C, Marks PA (2007) Histone deacetylase inhibitors: Overview and perspectives. Mol Cancer Res 5(10):981-989 (Pubitemid 350080267)
40. Du K, Herzig S, Kulkarni RN et al (2003) TRB3: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300:1574-1577 (Pubitemid 36682889)
41. Esrig BC, Frazee L, Stephenson SF et al (1977) The predisposition to infection following hemorrhagic shock. Surg Gynecol Obstet 144(6):915-917 (Pubitemid 8208522)
42. Fan J, Marshall JC, Jimenez M et al (1998) Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: Role in pulmonary inflammation following lipopolysaccharide. J Immunol 161:440-447 (Pubitemid 28285553)
43. Fan J, Kapus A, Li YH et al (2000) Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: Role of tumor necrosis factor. Am J Respir Cell Mol Biol 22(4):412-421 (Pubitemid 30343340)
44. Faraco G, Pancani T, Formentini L et al (2006) Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol 70(6):1876-1884 (Pubitemid 44771903)
45. Ferrante RJ, Kubilus JK, Lee J et al (2003) Histone deactylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23:9418-9427 (Pubitemid 37323042)
46. Fink MP, Delude RL (2005) Epithelial barrier dysfunction: A unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 21(2):177-196 (Pubitemid 40386748)
47. Fukudome EY, Kochanek AR, Li Y et al (2010) Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signal-regulated kinase =. J Surg Res 163(1):118-126
48. Fukudome EY, Li Y, Kochanek AR (2011) Pharmacologic resuscitation decreases circulating CINC-1 levels and attenuates hemorrhage-induced acute lung injury. Surgery in press
49. Gao T, Newton AC (2002) The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C. J Biol Chem 277(35):31585-31592 (Pubitemid 34968961)
50. Gonzales E, Chen H, Munuve R, Mehrani T, Britten-Webb J, Nadel A, Alam HB, Wherry D, Burris D, Koustova E (2006) Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones. Shock 25(4):395-401
51. Gonzales E, Chen H, Munuve RM, Mehrani T, Nadel A, Koustova E (2008) Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock. J Trauma 65(3):554-565
52. Gotoh T, Terada K, Oyadomari S et al (2004) hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell Death Differ 11(4):390-402 (Pubitemid 38489417)
53. Granger A, Abdullah I, Huebner F, Stout A, Wang T, Huebner T, Epstein JA, Gruber PJ (2008) Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 22:3549-3560
54. Haggarty SJ, Koeller KM, Wong JC et al (2003) Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 100(8):4389-4394 (Pubitemid 36457739)
55. Harlan JH, Winn RK (2002) Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy. Crit Care Med 30(5):S214-S219 (Pubitemid 34507993)
56. Hassoun HT, Kone BC, Mercer DW et al (2001) Post-injury multiple organ failure: The role of the gut. Shock 15(1):1-10 (Pubitemid 33598153)
57. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132(3):344-362
58. Hierholzer C, Billiar TR (2001) Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 386:302-308 (Pubitemid 32702760)
59. Hockly E, Richon VM, Woodman B et al (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in amousemodel of Huntington's disease. Proc Natl Acad Sci USA 100:2041-2046 (Pubitemid 36254570)
60. Hu E, Dul E, Sung CM et al (2003) Identification of novel isoform-selective inhibitors within class I histone deacetylases. J Pharmacol Exp Ther 307(2):720-728 (Pubitemid 37310689)
61. Huang N, Katz JP, Martin DR et al (1997) Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine 9(1):27-36 (Pubitemid 27148365)
62. Inan MS, Rasoulpour RJ, Yin L et al (2000) The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 118(4):724-734 (Pubitemid 30171622)
63. Inoue K, Kobayashi M, Yano K et al (2006) Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. Arterioscler Thromb Vasc Biol 26(12):2652-2659
64. Jaattela M, Wissing D, Kokholm K et al (1998) Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J 17(21):6124-6134 (Pubitemid 28497786)
65. Kelly WK, Marks PA (2005) Drug insight: Histone deacetylase inhibitors - development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nal Clin Pract Oncol 2(3):150-157 (Pubitemid 40823166)
66. Kiernan R, Bres V, Ng RW et al (2003) Post-activation turn-off of NF-kappaB-dependent transcription is regulated by acetylation of p65. J Biol Chem 278(4):2758-2766 (Pubitemid 36801357)
67. Kim AJ, Shi Y, Austin RC et al (2005) Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J Cell Sci 118:89-99 (Pubitemid 40277107)
68. Kim KH, Oudit GY, Backx PH (2008) Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. J Pharmacol Exp Ther 324:160-169 (Pubitemid 350294149)
69. Kim K, Li Y, Jin G et al. (2011) Effect of valproic acid on acute lung injury in a rodent model of intestinal ischemia reperfusion. Resuscitation in press
70. Kishimoto H, Hamada K, Saunders M, Backman S, Sasaki T, Nakano T et al (2003) Physiological functions of Pten in mouse tissues. Cell Struct Funct 28:11-21 (Pubitemid 36443125)
71. Kochenek AR, Fukudome EY, Eleanor JS et al (2010) Pharmacological resuscitation attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in rodent model. Oral presentation at the annual meeting of the American college of surgeons, October 2010
72. Kramer OH, Gottlicher M, Heinzel T (2001) Histone deacetylase as a therapeutic target. Trends Endocrinol Metab 12(7):294-300 (Pubitemid 33714220)
73. Krivoruchko A, Storey KB (2010) Epigenetics in anoxia tolerance: A role for histone deacetylase. Mol Cell Biochem 342(1-2):151-161
74. Kucharska A, Rushworth LK, Staples C et al (2009) Regulation of the inducible nuclear dual-specificity phosphatase DUSP5 by ERK MAPK. Cell Signal 21(12):1794-1805
75. Lane AA, Chabner BA (2009) Histone deacetylase inhibitors in cancer therapy. J Clin Oncol 27(32):5459-5468
76. Lee JO, Yang H, Georgescu MM et al (1999) Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association. Cell 99:323-334 (Pubitemid 29519911)
77. Leoni F, Fossati G, Lewis EC et al (2005) The histone deacetylase inhibitor ITF2357 reduction of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med 11:1-15
78. Li Y, Liu B, Sailhamer EA, Yuan Z, Shults C, Velmahos GC, deMoya M, Shuja F, Butt MU, Alam HB (2008a) Cell protective mechanism of valproic acid in lethal hemorrhagic shock. Surgery 144(2):217-224 (Pubitemid 352024388)
79. Li Y, Yuan Z, Liu B, Sailhamer EA, Shults C, Velmahos GC, Demoya M, Alam HB (2008b) Prevention of hypoxiainduced neuronal apoptosis through histone deacetylase inhibition. J Trauma 64(4):863-870 (Pubitemid 351521869)
80. Li Y, Liu B, Zhao H, Sailhamer EA, Fukudome EY, Zhang X, Kheirbek T, Finkelstein RA, Velmahos GC, deMoya CA, Hales RA, Alam HB (2009) Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents. Shock 32(5):517-523
81. Li Y, Liu B, Fukudome EY, Kochanek AR, Finkelstein R, Chong W, Jin G, Lu J, deMoya M, Velmahos GC, Alam HB (2010a) Survival lethal septic shock without fluid resuscitation in a rodent model. Surgery 148(2):246-254
82. Li Y, Liu B, Dillon S, Liu B et al (2010b) Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment. J Surg Res 159(1):474-481
83. Lillig CH, Holmgren A (2007) Thioredoxin and related molecules - from biology to health and disease. Antioxid Redox Signal 9(1):25-47 (Pubitemid 44901873)
84. Lin T, Alam HB, Chen H, Britten-Webb J, Rhee P, Kirkpatrick J, Koustova E (2006) Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation. Surgery 139:365-376
85. Lin T, Chen H, Koustova E, Sailhamer EA et al (2007) Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: Effect of different resuscitation strategies on lung and liver. Surgery 141(6):784-794 (Pubitemid 46856575)
86. Lomas-Niera JL, Perl M, Chung C et al (2005) Shock and hemorrhage: An overview of animal models. Shock 24(Suppl 1):33-39
87. Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375-13378 (Pubitemid 28268370)
88. Mai A, Massa S, Pezzi R et al (2003) Discovery of (aryloxopropenyl) pyrrolyl hydroxyamides as selective inhibitors of class IIa histone deacetylase homologue HD1-A. J Med Chem 46(23):4826-4829 (Pubitemid 37352021)
89. Marinova Z, Ren M, Wendland JR, Leng Y, Liang MH, Yasuda S, Leeds P, Chuang DM (2009) Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: A potential role of Sp1 acetylation. J Neurochem 111(4):976-987
90. Marks PA, Dokmanovic M (2005) Histone deacetylase inhibitors: Discovery and development as anticancer agents. Expert Opin Investig Drugs 14:1497-1511 (Pubitemid 41749195)
91. Marumo T, Hishikawa K, Yoshikawa M et al (2008) Epigenetic regulation of BMP7 in the regenerative response to ischemia. J Am Soc Nephrol 19:1311-1320
92. McCampbell A, Taye AA, Whitty L et al (2001) Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci USA 98:15179-15184 (Pubitemid 34013989)
93. Meriin AB, Yaglom JA, Gabai VL et al (1999) Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: A novel pathway controlled by HSP72. Mol Cell Biol 19(4):2547-2555 (Pubitemid 29144498)
94. Mollen KP, Levy RM, Prince JM et al (2008) Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells. J Leukoc Biol 83(1):80-88
95. Morin PJ (2005) Claudin proteins in human cancer: Promising new targets for diagnosis and therapy. Cancer Res 65(21):9603-9606 (Pubitemid 41541431)
96. Mosser DD, Caron AW, Bourget L et al (2000) The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 20(19):7146-7159
97. Moochhala S, Wu J, Lu J (2009) Hemorrhagic shock: An overview of animal models. Front Biosci 14:4631
98. Murphy TJ, Paterson HM, Mannick JA, Lederer JA (2004) Injury, sepsis, and the regulation of toll-like receptor responses. J Leukoc Biol 75(3):400-407 (Pubitemid 38316369)
99. Okumura K, Mendoza M, Bachoo RM et al (2006) PCAF modulates PTEN activity. J Biol Chem 281:26562-26568 (Pubitemid 44401865)
100. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH (2004) The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37:449-471 (Pubitemid 38953373)
101. Park HS, Cho SG, Kim CK et al (2002) Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol Cell Biol 22(22):7721-7730 (Pubitemid 35217284)
102. Peitzman AB, Billiar TR, Harbrecht BG et al (1995) Hemorrhagic shock. Curr Probl Surg 32(11):925-1002
103. Perkins ND (2007) Integrating cell-signaling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8(1):49-62 (Pubitemid 46012014)
104. Petri S, Kiaei M, Kipiani K et al (2006) Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 22:40-49
105. Petri B, Phillipson M, Kubes P (2008) The physiology of leukocyte recruitment: An in vivo perspective. J Immunol 180:6439-6446
106. Ping P, Murphy E (2000) Role of p38 mitogen-activated protein kinases in preconditioning: A detrimental factor or a protective kinase? Circ Res 86(9):989-997
107. Quivy V, Adam E, Collette Y et al (2002) Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: Potential perspectives for the development of therapeutic strategies. J Virol 76(21):11091-11103 (Pubitemid 35176225)
108. Rana MW, Singh G, Wang P et al (1992) Protective effects of preheparinization on the microvasculature during and after hemorrhagic shock. J Trauma 32:420-426
109. Roger TH, Babensee JE (2010) Altered adherent leukocyte profile on biomaterials in toll-like receptor 4 deficient mice. Biomaterials 31(4):594-601
110. Ryu H, Lee J, Plpfsson BA et al (2003) Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via a Sp1-dependent pathway. Proc Nalt Acad Sci USA 100(7):4281-4286 (Pubitemid 36418194)
111. Ryu H, Smith K, Camelo SI et al (2005) Sodium phenylbutyrate prolongs survival and regulates expression of antiapoptotic genes in transgenic amyotrophic lateral sclerosis. J Neurochem 93:1087-1098 (Pubitemid 40776564)
112. Saccani S, Pantano S, Natoli G (2002) p38-depedent marking of inflammatory genes for increased NF-kB recruitment. Nat Immunol 3(1):69-75 (Pubitemid 34065620)
113. Saha RN, Pahan K (2006) HATs and HDACs in neurodegeneration: A tale of disconcerted acetylation homeostasis. Cell Death Differ 13:539-550
114. Sailhamer ES, Li Y, Smith EJ et al (2008) Acetylation: A novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans. Surgery 144(2):204-216 (Pubitemid 352024386)
115. Saitoh M, Nishitoh H, Fujii M et al (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17:2596-26026
116. Saleh A, Srinivasula SM, Balkir L et al (2000) Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2:476-483
117. Schwartzbauer G, Robbins J (2001) The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem 276:35786-35793
118. Scher MB, Vaquero A, Reinberg D (2007) SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev 21(8):920-928 (Pubitemid 46625641)
119. Shih HC, Wei YH, Lee CH (2003) Magnolol alters cytokine response after hemorrhagic shock and increases survival in subsequent intraabdominal sepsis in rats. Shock 20(3):264-268
120. Shuja F, Tabbara M, Li Y, Liu B, Butt MU, Velmahos GC, deMoya M, Alam H (2009) Profound hypothermia decreases cardiac apoptosis through Akt survival pathway. J Am Coll Surg 209:89-99
121. Shults C, Sailhamer EA, Li Y, Liu B, Tabbara M, Butt MU, Shuja F, Demoya M, Velmahos G, Alam HB (2008) Surviving blood loss without fluid resuscitation. J Trauma 64(3):629-638 (Pubitemid 351366882)
122. Stambolic V, Suzuki A, de la Pompa JL et al (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39 (Pubitemid 28458022)
123. Stankiewicz AR, Lachapelle G, Foo CP et al (2005) Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J Biol Chem 280(46):38729-38739 (Pubitemid 43853776)
124. Steffan JS, Bodai L, Pallos J et al (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413:739-743 (Pubitemid 33009952)
125. Stiles B, Groszer M, Wang S et al (2004) PTENless means more. Dev Biol 273:175-184 (Pubitemid 39144393)
126. St-pierre J, Drori S, Uldry M et al (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127(2):397-408 (Pubitemid 44572377)
127. Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19(5):233-238 (Pubitemid 36511427)
128. Suuronen T, Ojala J, Hyttinen JM et al (2008) Regulation of ER alpha signaling pathway in neuronal HN10 cells: Role of protein acetylation and Hsp90. Neurochem Res 33(9):1768-1775
129. Suzuki T (2009) Explorative study on isoform-selective histone deacetylase inhibitors. Chem Pharm Bull 57(9):897-906
130. Tamguney T, Strokoe D (2007) New insight into PTEN. J Cell Sci 120(Pt23):4071-4079
131. Thomson S, Clayton AL, Hazzalin CA et al (1999) The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J 18(17):4779-4793 (Pubitemid 29415531)
132. Thuijls G, de Haan JJ, Derikx JP et al (2009) Intestinal cytoskeleton degradation precedes tight junction loss following hemorrhagic shock. Shock 31:164-169
133. Torella D, Rota M, Nurzynska D, Musso E, Monsen A, Shiraishi I et al (2004) Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 94:514-524 (Pubitemid 38326287)
134. Tsan MF, Gao B (2009) Heat shock proteins and immune system. J Leukoc Biol 85(6):905-910
135. Ungerstedt JS, Sowa Y, Xu WS et al (2005) Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Pro Natl Acad Sci USA 102(3):673-678 (Pubitemid 40282724)
136. Vadlamani L, Lyengar S (2004) Tumor necrosis factor alpha polymorphism in heart failure/cardiomyopathy. Congest Heart Fail 10(6):289-292
137. Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44-84 (Pubitemid 44566469)
138. Vanden Berghe W, De Bosscher K, Boone E et al (1999) The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem 274(45):32091-32098
139. Vidali G, Gershey E, Allfrey VG (1968) Chemical studies of histone acetylation. The distribution of e-N-acetyllysine in calf thymus histones. J Biol Chem 243:6361-6366
140. Voelter-Mahlknecht S, Ho AD, Mahlknecht U (2005) Chromasomal organization and localization of novel class IV human histone deacetylase 11 gene. Int J Mol Med 16(4):589-598
141. Volloch V, Gabai VL, Rits S et al (1999) ATPase activity of the heat shock protein hsp72 is dispensable for its effects on dephosphorylation of stress kinase JNK and on heat-induced apoptosis. FEBS Lett 461(1-2):73-76 (Pubitemid 29528573)
142. Weichert W (2009) HDAC expression and clinical prognosis in human malignancies. Cancer Lett 280(2):168-176
143. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365-376 (Pubitemid 19106873)
144. Winter-Vann AM, Johnson GL (2007) Integrated activation of MAP3Ks balances cell fate in response to stress. J Cell Biochem 102(4):848-858 (Pubitemid 350036925)
145. Wong V, Gumbiner BM (1997) A synthetic peptide corresponding to the extracellular domain of occluding perturbs the tight junction permeability barrier. J Cell Biol 136:399-409 (Pubitemid 27063089)
146. Xu YX, Ayala A, Chaudry IH (1998) Prolonged immunodepression after trauma and hemorrhagic shock. J Trauma 44:335-341 (Pubitemid 28124174)
147. Yao XH, Nyomba BL (2008) Hepatic resistance induced by prenatal alcohol exposure is associated with reduced PTEN and TRB3 acetylation in adult rat offspring. Am J Physiol Regul Integr Comp Physiol 294(6):R1797-R1806
148. Yellon DM, Downey JM (2003) Preconditioning the myocardium: From cellular physiology to clinical cardiology. Physiol Rev 83:1113-1151 (Pubitemid 37222269)
149. Yildirim F, Gertz K, Kronenberg G et al (2008) Inhibition of histone deacetylation protects wildtype but not gelsolindeficient mice from ischemic brain injury. Exp Neurol 210(2):531-542
150. Zacharias N, Sailhamer EA, Li Y, Liu B, Butt MU, Shuja F, Velmahos GC, de Moya M, Alam HB et al (2010) Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells. Resuscitation, 29 October 2010 [Epub ahead of print]
151. Zarbock A, Ley K (2009) Neutrophil adhesion and activation under flow. Microcirculation 16:31-42
152. Zhang L, Wan J, Jiang R et al (2009) Protective effects of trichostatin A on liver injury in septic mice. Hepatol Res 39:931-938
153. Zhang L, Jin S, Wang C et al (2010) Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. World J Surg 34(7):1676-1683
154. Zhao TC, Cheng G, Zhang LX et al (2007) Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res 76(3):473-481 (Pubitemid 350007465)